Photo 1 (IMAGE)

The University of Hong Kong

Photo 1

Caption

A cross-institutional research team led by Professor Wang Weiping (first left) has developed a novel cinnamaldehyde-based prodrug nanomedicine that can precisely deliver the therapeutic agents to the inflamed sites, offering a solution to the treatment of inflammatory diseases.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.